2026-07-01T08:49:16-05:00 2025-12-31 410746749 CLIFTONLARSONALLEN LLP 14815 BALLANTYNE VILLAGE WAY SUITE 300 CHARLOTTE NC 28277 990 2025-01-01 591893881 FLORIDA ASSOCIATION OF PEDIATRIC TUMORS PROGRAM INC FLOR 8133969528 3650 SPECTRUM BLVD 100 TAMPA FL 336129446 BRIAN CALKINS PROGRAM DIRECTOR 8133969528 2026-06-29 1 KATHRINE A WARLICK P02065266 7049985200 2026-06-29 2025 2025-03-06 01:10:19Z BRIAN CALKINS 3650 SPECTRUM BLVD 100 TAMPA FL 336129446 753856 0 X FAPTP.EPI.USF.EDU X 1973 FL SCIENTIFIC RESEARCH AND EDUCATION IN PEDIATRIC ONCOLOGY AND HEMATOLOGY 15 14 2 15 0 0 679821 705945 31671 21612 18984 26299 0 0 730476 753856 9165 14760 0 0 145017 191740 0 0 0 522192 520365 676374 726865 54102 26991 661722 689841 59122 60850 602600 628991 X TO UNITE FLORIDA PHYSICIANS INTERESTED AND KNOWLEDGEABLE IN PEDIATRIC ONCOLOGY AND HEMATOLOGY, PROMOTE THE SCIENCE AND PRACTICE OF THE VARIOUS SPECIALTIES, AND HELP MAINTAIN HIGH STANDARDS OF CARE AND RESEARCH. 0 0 496475 0 0 RESEARCH INITIATIVES: FLORIDA ASSOCIATION OF PEDIATRIC TUMORS PROGRAM, INC. (FAPTP) COLLECTS DATA FROM MEMBER INSTITUTIONS TO CONDUCT EPIDEMIOLOGIC STUDIES, CLINICAL TRIALS, AND CANCER-CONTROL PROTOCOLS. THE FLORIDA CANCER DATA SYSTEM (FCDS) CAPTURES DATA FROM PATIENTS TREATED OUTSIDE THE FAPTP SYSTEM AND CAN BE LINKED WITH THE SPIRS DATA TO STUDY A LARGER PATIENT BASE. WITH THE COMBINED DATA SET, FAPTP STAFF CAN BETTER IDENTIFY THE INCIDENCE OF PEDIATRIC CANCER IN FLORIDA. STUDIES AND PROJECTS CURRENTLY OPEN INCLUDE: CALCULATING THE INCIDENCE OF PEDIATRIC CANCER IN EACH OF FLORIDA'S 67 COUNTIES TO IDENTIFY TEMPORAL OR GEOGRAPHIC TRENDS THAT WARRANT FURTHER INVESTIGATION EXAMINING POSSIBLE ASSOCIATION BETWEEN ENVIRONMENTAL HAZARDS AND POTENTIAL CANCER CLUSTERS. (CONTINUED ON SCHEDULE O)FAPTP SITES ACTIVELY PARTICIPATE IN CLINICAL TREATMENT TRIALS FROM THE CHILDREN'S ONCOLOGY RESEARCH BASE. FAPTP IS ALSO INVOLVED IN THE DEVELOPMENT OF NEW CANCER-CONTROL STUDIES; TWO CURRENT STUDIES HAVE BEEN APPROVED BY THE NCI FOR CANCER-CONTROL CREDIT AS INTERGROUP STUDIES WITH CHILDREN'S ONCOLOGY GROUP (COG). 132393 0 0 REPORTING SYSTEM:THE FLORIDA LEGISLATURE ESTABLISHED A HEMATOLOGY/ONCOLOGY PROGRAM IN CHILDREN MEDICAL SERVICES (CMS) AND FAPTP WAS GIVEN THE RESPONSIBILITY AND AUTHORITY TO MONITOR AND EVALUATE CHILDREN'S CANCER CARE IN FLORIDA AND TO PREPARE ANNUAL RECOMMENDATIONS TO CMS REGARDING PROGRAM PLANNING AND DEVELOPMENT. THIS REPORTING SYSTEM PROVIDES THE STATE AND THE PUBLIC WITH DATA ON CANCER INCIDENCE, CLINICAL-TRIAL PARTICIPATION, AND SURVIVORSHIP. THIS INFORMATION AIDS INVESTIGATORS IN STUDIES CONDUCTED ON BOTH THE STATE AND NATIONAL LEVEL. HISTORICALLY, FAPTP ASSISTED THE STATE IN EVALUATING AND ADMINISTERING THE INFANT SCREENING PROGRAM FOR SICKLE CELL DISEASE.(CONTINUED ON SCHEDULE O)CURRENTLY, FAPTP MAINTAINS MEMBERSHIP ON THE GOVERNOR'S FLORIDA CANCER CONTROL AND RESEARCH ADVISORY COUNCIL (C-CRAB), ASSISTING THE COUNCIL IN THE DEVELOPMENT OF THE FLORIDA STATE CANCER PLAN. 33098 14760 21612 EDUCATIONAL AND RESEARCH PROGRAMS:THE PROGRAMS HELP TO MEET THE GROWING DEMANDS FOR ACCURATE AND CREDIBLE INFORMATION FROM THE MEMBER INSTITUTIONS AND THE STATE OF FLORIDA. THIS YEAR (2025) WAS THE 48TH YEAR OF OUR EDUCATIONAL SEMINAR, WHICH PROVIDES EDUCATIONAL OPPORTUNITIES FOR HEALTHCARE PERSONNEL. THIS IS A UNIQUE OPPORTUNITY TO FURTHER ENHANCE THE LEVEL OF CARE FOR CHILDREN WITH CANCER AND BLOOD DISORDERS. THE SEMINAR PROVIDES CONTINUING EDUCATION FOR HEALTHCARE PROFESSIONALS AND A FORUM TO DISCUSS TREATMENT AND SUPPORTIVE CARE ISSUES WITH NATIONALLY RENOWNED EXPERTS. THIS YEAR'S VIRTUAL SEMINAR DREW APPROXIMATELY 220 NURSES AND OTHER HEALTH PROFESSIONALS.(CONTINUED ON SCHEDULE O)PARTICIPANTS FROM OUTSIDE OF FLORIDA COMPRISE MORE THAN HALF OF THE TOTAL ATTENDANCE, DEMONSTRATING THE NATIONAL RECOGNITION OF THE SEMINAR. 661966 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 6 0 1 2 1 0 0 0 0 0 0 0 0 0 0 0 0 X 15 14 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 0 FL X BRIAN J CALKINS 8133969525 3650 SPECTRUM BLVD SUITE 100 TAMPA FL 33612 EMAD SALMAN MD PRESIDENT 2.00 X X 18659 0 0 HECTOR RODRIGUEZ-CORTES MD VICE PRESIDENT 1.00 X X 0 0 0 IFTIKHAR HANIF MD SECRETARY/TREASURER 1.00 X X 0 0 0 SCOTT BRADFIELD MD OFFICER 1.00 X X 0 0 0 DOURED DAGHISTANI MD DIRECTOR 1.00 X 0 0 0 DON ESLIN MD DIRECTOR 1.00 X 0 0 0 ANDREW J GALLIGAN MD DIRECTOR 1.00 X 0 0 0 FOUAD HAJJAR MD DIRECTOR 1.00 X 0 0 0 CASSANDRA JOSEPHSON MD DIRECTOR 1.00 X 0 0 0 ZIAD KHATIB MD DIRECTOR 1.00 X 0 0 0 CRAIG MACARTHUR MD DIRECTOR 1.00 X 0 0 0 JAIME LIBES-BANDER MD DIRECTOR 1.00 X 0 0 0 MATTHEW RAMIREZ MD DIRECTOR 1.00 X 0 0 0 WILLIAM SLAYTON MD DIRECTOR 1.00 X 0 0 0 MARY TOTH MD DIRECTOR 1.00 X 0 0 0 BRIAN J CALKINS PROGRAM DIRECTOR 40.00 X 131892 0 17456 JEFFREY P KRISCHER EXECUTIVE DIRECTOR 2.00 X 0 0 0 150551 0 17456 1 0 0 0 0 705945 705945 SEMINARS 611710 21612 21612 21612 26299 26299 753856 21612 0 26299 X 14760 14760 149348 112011 37337 18033 13525 4508 2221 1666 555 10539 7904 2635 11599 8699 2900 26513 12992 13521 406187 406187 5889 5850 39 15116 13453 1663 960 960 1545 1545 RESEARCH REIMBURSTMENT 57634 57634 EMPLOYEE APPRECIATION 6521 6325 196 726865 661966 64899 0 486917 507666 123925 131895 6410 6410 0 0 50880 50280 661722 689841 59122 60850 59122 60850 X 602600 628991 602600 628991 661722 689841 26991 -600 0 X 1 X 0 0 0 X 733500 746187 760573 679821 705945 3626026 733500 746187 760573 679821 705945 3626026 3626026 3121 5306 11919 18984 26299 65629 3691655 120241 0.98220 0.98830 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 6410 6410 0 0 X PART X, LINE 2: FAPTP IS A NONPROFIT ORGANIZATION THAT IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) AND, ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS. THE ORGANIZATION RECOGNIZES INTEREST ACCRUED RELATED TO UNRECOGNIZED TAX BENEFITS IN INTEREST EXPENSE AND PENALTIES IN PROGRAM EXPENSES. DURING THE YEARS ENDED DECMEBER 31, 2025 AND 2024, THE ORGANIZATION DID NOT INCUR ANY INTEREST OR PENALITIES RELATED TO TAX POSITIONS. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE PRESIDENT AND DESIGNATED MEDICAL DIRECTORS FROM EACH MEMBER INSTITUTION. THE EXECUTIVE COMMITTEE SHALL APPROVE ALL COMMITTEE APPOINTMENTS MADE BY THE PRESIDENT AND APPROVE THE EDUCATIONAL PROGRAMS OF THE ASSOCIATION. THE EXECUTIVE COMMITTEE SHALL GOVERN THE OFFICERS OF THE ASSOCIATION IN ACCORDANCE TO THE ARTICLES OF INCORPORATION AND BYLAWS. ADDITIONAL RESPONSIBILITIES INCLUDE FUNDRAISING FOR THE ASSOCIATION, APPROVAL OF THE CENTRAL OFFICE POLICIES AND PROCEDURES, APPROVAL OF THE SELECTION OF AN INDEPENDENT AUDITOR TO CONDUCT ANNUAL AUDIT OF ASSOCIATION ACCOUNTS, AND REVIEW AND ACCEPTANCE OF THE AUDIT. THE EXECUTIVE COMMITTEE SHALL ALSO ENSURE THAT THE ASSOCIATION DOES NOT ENGAGE IN ANY ACTIVITY WHICH WILL JEOPARDIZE ITS FEDERAL OR STATE TAX EXEMPT STATUS. WHILE THE EXECUTIVE COMMITTEE IS AUTHORIZED TO ACT ON BEHALF OF THE FULL GOVERNING BODY, SUCH AUTHORITY IS LIMITED AND TYPICALLY EXERCISED ONLY IN EMERGENCY SITUATIONS OR WHEN TIMELY DECISIONS ARE REQUIRED BETWEEN FULL BOARD MEETINGS. ALL ACTIONS TAKEN UNDER DELEGATED AUTHORITY ARE SUBJECT TO RATIFICATION BY THE FULL BOARD AT ITS NEXT SCHEDULED MEETING. FORM 990, PART VI, SECTION A, LINE 6 THE ASSOCIATION SHALL BE COMPOSED OF THE FOLLOWING CLASSIFICATION OF MEMBERS: 1. FULL MEMBERS IN ACCORDANCE WITH THE ARTICLES OF INCORPORATION, PHYSICIANS LICENSED IN THE STATE OF FLORIDA ENGAGED IN RESEARCH AND/OR CLINICAL PRACTICE OF AN AREA OF SPECIALTY RELATED TO PEDIATRIC HEMATOLOGY/ONCOLOGY WHO EXPRESS A COMMITMENT TO QUALITY PEDIATRIC HEMATOLOGY/ONCOLOGY CARE FOR FLORIDA'S CHILDREN QUALIFY AS FULL MEMBERS. 2. ASSOCIATE MEMBERS INDIVIDUALS WITH TRAINING AND EXPERTISE IN DISCIPLINES OTHER THAN MEDICINE (SUCH AS NURSING, SOCIAL WORK, DATA MANAGEMENT, PHARMACY, BIOSTATISTICS, ETC.) RELATED TO THE DIAGNOSIS OR TREATMENT OF CHILDHOOD CANCER AND BLOOD DISORDERS OR HAVE AN INTEREST IN IMPROVING THE CARE OF CHILDREN WITH CANCER QUALIFY AS ASSOCIATE MEMBERS. 3. INSTITUTIONAL MEMBERS INSTITUTIONAL MEMBERSHIP COMPETENCE REQUIREMENT: AN INSTITUTIONAL MEMBER MUST MEET THE GENERAL CRITERIA AND GUIDELINES FOR PEDIATRIC CANCER CENTERS ESTABLISHED AND PUBLISHED BY THE SECTION ON HEMATOLOGY-ONCOLOGY OF THE AMERICAN ACADEMY OF PEDIATRICS AND THE AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY. FORM 990, PART VI, SECTION A, LINE 7A ALL CLASSES OF MEMBERS ARE ELIGIBLE TO VOTE ON THE MEMBERS OF THE GOVERNING BODY. FORM 990, PART VI, SECTION A, LINE 7B THE BYLAWS MAY BE ALTERED, AMENDED, REPEALED, OR ADDED TO BY AN AFFIRMATIVE VOTE OF TWO-THIRDS OF THE MEMBERS PRESENT AT THE ANNUAL MEETING OR ANY SPECIAL MEETING PROPERLY CALLED AND CONSTITUTED. APPROVAL OF THE PROPOSED BYLAWS CHANGES MAY ALSO BE CONDUCTED BY MAIL. FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS REVIEWED BY THE EXECUTIVE OFFICERS, EXECUTIVE DIRECTOR, AND THE PROGRAM DIRECTOR PRIOR TO SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS IN PLACE TO MAINTAIN BEST PRACTICES FOR ENSURING OBJECTIVITY IN RESEARCH AND PRESERVE THE CREDIBILITY OF THE FLORIDA PEDIATRIC NCORP AND ITS PARTICIPATING RESEARCHERS, FACULTY, AND PROFESSIONAL STAFF THROUGH A TRANSPARENT PROCEDURE FOR CONFLICT DISCLOSURE AND RESOLUTION. THE POLICY IS GUIDED BY FEDERAL REGULATORY REQUIREMENTS FOR THE DISCLOSURE, REVIEW, MANAGEMENT, AND REPORTING OF CONFLICTS, MANDATED IN THE DHHS/PHS REGULATIONS 42 CFR PART 50. THE POLICY APPLIES TO ALL FLORIDA PEDIATRIC NCORP PARTICIPANTS, INCLUDING RESEARCHERS, FACULTY, AND PROFESSIONAL STAFF, WHO ARE INVOLVED IN THE DESIGN, CONDUCT, OR REPORTING OF RESEARCH. THE POLICY REQUIRES INVESTIGATORS TO DISCLOSE THEIR SIGNIFICANT FINANCIAL INTERESTS AND EXTRAMURAL ACTIVITIES THAT ARE REASONABLY RELATED TO THEIR INSTITUTIONAL RESPONSIBILITIES FOR THE PREVIOUS 12 MONTHS, AS WELL AS ANY ESTIMATED VALUES FOR ANY SIGNIFICANT FINANCIAL INTEREST OR EXTRAMURAL ACTIVITY EXPECTED OVER THE NEXT 12 MONTHS. ALL INVESTIGATORS MUST COMPLETE FINANCIAL CONFLICT OF INTEREST TRAINING. INVESTIGATORS MUST UPDATE THEIR DISCLOSURE FORMS WITHIN 30 DAYS OF RECEIVING EQUITY OR REMUNERATION FOR A NEW EXTRAMURAL ACTIVITY OR WHEN THEY OR THEIR IMMEDIATE FAMILY OR HOUSEHOLD MEMBERS ACQUIRE A NEW SFI RELATED TO AN INVESTIGATOR'S INSTITUTIONAL RESPONSIBILITIES. THE POLICY APPLIES TO ALL BOARD MEMBERS AND DIRECTORS. THE PRINCIPAL INVESTIGATOR IS RESPONSIBLE FOR REVIEWING AND MONITORING DISCLOSURES FROM ALL DIRECTORS ON-SITE AND REPORTING ANY ACTIVITIES THAT MAY PRESENT A CONFLICT OF INTEREST. CONFLICT DETERMINATIONS ARE MADE AT THE PRINCIPAL INVESTIGATOR LEVEL, AND ACTUAL CONFLICTS ARE REVIEWED ANNUALLY PRIOR TO THE BOARD MEETING. INDIVIDUALS IDENTIFIED AS HAVING A CONFLICT ARE SUBJECT TO RESTRICTIONS, INCLUDING REMOVAL FROM THE BOARD AND LOSS OF VOTING RIGHTS. THEY ARE PROHIBITED FROM PARTICIPATING IN ANY DELIBERATIONS OR DECISIONS RELATED TO THE TRANSACTION OR MATTER IN QUESTION. THESE SAFEGUARDS ENSURE THAT ALL DECISIONS ARE MADE IN THE BEST INTEREST OF THE ORGANIZATION AND MAINTAIN COMPLIANCE WITH FEDERAL AND STATE TAX-EXEMPT REQUIREMENTS. FORM 990, PART VI, SECTION B, LINE 15 THE PROGRAM DIRECTOR'S SALARY IS ASSESSED BY THE EXECUTIVE DIRECTOR ON AN ANNUAL BASIS AT THE TIME OF THE EMPLOYEE'S ANNUAL PERFORMANCE EVALUATION. INCREASES ARE BASED ON THE COST OF LIVING INCREASES, THE EMPLOYEE'S WORK PERFORMANCE, AND AVAILABILITY OF FUNDS. A SALARY HISTORY IS KEPT IN THE EMPLOYEE'S PERSONNEL FILE. THE PROCESS DESCRIBED HERE WAS LAST COMPLETED IN 2025. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G RESEARCH CONSULTING: PROGRAM SERVICE EXPENSES 406,187. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 406,187.